ZJYL Jin Medical International: Debt to Equity

Jin Medical International Ltd - graphic logo of issuer ZJYL

Jin Medical International (ZJYL) specializes in the production of electric and mechanical wheelchairs for people with limited mobility. This price chart on GURU.Markets confirms that the debt-to-equity ratio is 0.68. The business relies on global exports and cost-effective manufacturing in the PRC. Scaling through workshop automation enables the company to effectively penetrate Western markets. The firm is currently actively expanding the distribution of innovative rehabilitation equipment.

ZJYL: Jin Medical International Ltd. Debt to Capital 02/21/2024 - 11/01/2026
Finished products of Jin Medical

To identify the sector's fundamental leaders, the analyst evaluates the ratio of total liabilities to net assets, which determines the actual pace of balance sheet deleveraging and resilience to rising interest rates. Given the limited pricing power of Jin Medical International (ZJYL) and pressure from distributors, calculating the total debt-to-equity ratio is critical for assessing portfolio impairment risks in the event of declining margins.

Key competitors

Debt to Equity Boston Scientific Corporation|Edwards (EW) - Total Debt to Capital Coefficient|Debt to Equity ResMed Corp (RMD)|PODD: Aggregate Debt to Equity|Total Debt to Capital ZBH (Zimmer Biomet Corp)|coopercos.com (COO) - Debt to Capital|Align Technology - Total Debt to Capital|Globus Medical Inc (GMED) - Total Debt to Equity Ratio|TMDX: Total Debt to Capital|ATEC - Total Debt to Capital Coefficient|AORT (Artivion, Inc.) - Total Debt to Capital|Total Debt to Capital enovis.com|Debt to Equity Integra LifeSciences Holdings Corporation (IART)|Debt to Equity ESTA (Establishment Labs Corp)|Total Debt to Capital BBNX (Beta Bionics Corp)|Total Debt to Capital Coefficient IRADIMED Inc. (IRMD)|EMBC: Total Debt to Equity Ratio|Aggregate Debt to Equity TNDM|AXGN: Total Debt to Capital|Debt to Capital SI-BONE Inc (SIBN)|OFIX (Orthofix International) - Total Debt to Capital|Debt to Equity Ratio BVS (Bioventus Global)|Total Debt to Equity Ratio KIDS (OrthoPediatrics Corp.)|TMCI (treace.com) - All Debt to Shareholders' Equity Ratio|Debt to Equity Strata Critical Medical SRTA|CARL - Total Debt to Equity Ratio|RxSight Corp - Total Debt to Capital|Debt to Capital ClearPoint Neuro, Inc.|STXS: Total Debt to Capital|Debt to Equity Ratio STIM|SGHT (Sight Sciences) - Total Debt to Capital|Orchestra BioMed Inc. (OBIO) - Total Debt to Capital Coefficient|Total Debt to Capital ANIK|Total Debt to Equity Ratio InspireMD Inc. NSPR|Total Debt to Capital VANI (Vivani Medical)|Total Debt to Capital Xtant Medical Holdings, Inc. XTNT|NMTC - Debt to Equity|MODD: Debt to Equity|MYO (Myomo, Inc) - Total Debt to Equity Ratio|Envoy Medical Inc - All Debt to Shareholders' Equity Ratio|VVOS (Vivos Therapeutics) - Total Debt to Capital|Debt to Capital envveno.com NVNO|Debt to Equity Sintx Technologies (SINT)|Tenon Medical Inc. (TNON) - Debt to Capital Ratio|ReWalk Robotics Ltd - Total Debt to Equity Ratio|Total Debt to Capital Autonomix Medical Inc. AMIX|INVO Fertility Inc - Total Debt to Capital|Total Debt to Capital Coefficient bonebiologics.com BBLG|Axonics (AXNX) - Debt to Equity|Aggregate Debt to Equity BIOL (BIOLASE Inc.)|Debt to Equity Dynatronics Corp|Total Debt to Equity Ratio Paragon 28 Corp (FNA)|Total Debt to Capital INVO